DIH Holding US (NASDAQ:DHAI) Issues Quarterly Earnings Results

DIH Holding US (NASDAQ:DHAIGet Free Report) released its quarterly earnings results on Monday. The company reported ($1.44) earnings per share for the quarter, Zacks reports. The company had revenue of $12.65 million during the quarter.

DIH Holding US Stock Performance

Shares of NASDAQ DHAI opened at $3.09 on Wednesday. DIH Holding US has a 52 week low of $2.75 and a 52 week high of $73.25. The stock has a market capitalization of $5.84 million, a P/E ratio of -0.41 and a beta of 0.02. The stock’s fifty day moving average is $5.36 and its 200 day moving average is $5.47.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DIH Holding US in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, DIH Holding US currently has a consensus rating of “Sell”.

Get Our Latest Stock Analysis on DHAI

Hedge Funds Weigh In On DIH Holding US

An institutional investor recently bought a new position in DIH Holding US stock. XTX Topco Ltd bought a new position in DIH Holding US, Inc. (NASDAQ:DHAIFree Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 119,994 shares of the company’s stock, valued at approximately $29,000. XTX Topco Ltd owned approximately 0.25% of DIH Holding US as of its most recent SEC filing. 27.76% of the stock is owned by institutional investors and hedge funds.

DIH Holding US Company Profile

(Get Free Report)

DIH Holding US, Inc operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement.

Read More

Receive News & Ratings for DIH Holding US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIH Holding US and related companies with MarketBeat.com's FREE daily email newsletter.